|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
BullFrog AI Partners with Eleison Pharmaceuticals to Optimize Phase 3 Oncology Trial Using AI
BullFrog AI (Nasdaq: BFRG) is teaming up with Eleison Pharmaceuticals to enhance Eleison’s pivotal Phase 3 trial for glufosfamide, an investigational pancreatic cancer treatment. Utilizing its bfLEAP® AI technology, BullFrog AI will analyze clinical data to refine patient selection, improve trial efficiency, and accelerate drug development. With pancreatic cancer impacting over 510,000 people worldwide annually and limited treatment options available, this collaboration aims to bring life-saving therapies to market faster. Eleison expects to complete the trial in 2027.
|
|
|
|
ConnectM Slashes Debt by $31M, Eyes Debt-Free Status by Q2 2025
ConnectM Technology Solutions (Nasdaq: CNTM) continues its financial turnaround, eliminating $31 million in liabilities since going public and reducing outstanding debt to under $10 million. With a $45 million revenue run rate and expectations to reach operating cash flow breakeven in Q1 2025, the company is on track to be debt-free by Q2. As a leader in AI-powered electrification solutions, ConnectM is positioning itself for strong growth in the clean energy sector.
|
|
|
|
|
VSee Health Partners with LanguageLine to Eliminate Language Barriers in Telehealth
VSee Health (Nasdaq: VSEE) enhanced its telehealth platform through a strategic partnership with LanguageLine Solutions, enabling seamless, real-time interpreter access in over 240 languages. With the global digital health market projected to surpass $787 billion, this collaboration is expected to drive adoption, improve provider efficiency, and unlock new revenue streams. By integrating one-touch language support, VSee is breaking down barriers to virtual care, ensuring equitable healthcare access for diverse patient populations while strengthening its position in the fast-growing telehealth sector.
|
|
|
|
|
|
|
Better Choice Company Moves Forward with $125M Acquisition of SRx Health Solutions
Better Choice Company (NYSE American: BTTR) has received final court approval to proceed with its $125 million acquisition of SRx Health Solutions, a leading Canadian specialty pharmacy provider. The combined company is expected to generate $270M+ in revenue and $10M+ in EBITDA in 2025, positioning itself as a global leader in health and wellness solutions. SRx shareholders will own approximately 85% of the new entity, with Better Choice shareholders retaining 15%. A special shareholder meeting is set for March 21, 2025, to finalize the transaction, which is expected to close in Q2 2025.
|
|
|
|
|
Gorilla Technology Showcased in Nasdaq Amplify Spotlight, Highlighting AI-Driven Global Expansion
Gorilla Technology (Nasdaq: GRRR) was featured in the Nasdaq Amplify Issuer Spotlight, where CEO Jay Chandan discussed the company’s AI-powered innovations in smart cities, cybersecurity, and sustainability. With a consultative approach tailored to government and enterprise needs, Gorilla is driving next-gen security and intelligence solutions worldwide. The feature reinforces the company's growing role in global AI adoption and digital transformation, solidifying its position as a leader in smart infrastructure and data-driven security.
|
|
|
Recent News
|
|
|
Unlock Smarter Investing with RedChat
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
Access RedChat now, free of charge.
|
|
|
|
Recent Research Coverage Updates

| Company |
Rating |
Price Target |
Firm |
Report Date |
| Enlivex Therapeutics (NASDAQ: ENLV) |
Buy |
$13 |
D. Boral |
February 7, 2025 |
| Gorilla Technology Group (NASDAQ: GRRR) |
Buy |
$18 |
Northland Capital Markets |
January 22, 2025 |
| OS Therapies (NYSE American: OSTX) |
Buy |
$9 |
Brookline |
January 15, 2025 |
| OS Therapies (NYSE American: OSTX) |
Buy |
$15 |
Maxim |
January 15, 2025 |
| OS Therapies (NYSE American: OSTX) |
Buy |
$20 |
D Boral Capital |
January 15, 2025 |
| Gorilla Technology Group (NASDAQ: GRRR) |
Buy |
$3 |
ThinkEquity |
January 13, 2025 |
| Venu Holding Corp. (NYSE American: VENU) |
Buy |
$15 |
ThinkEquity |
January 6, 2025 |
| Gorilla Technology Group (NASDAQ: GRRR) |
Buy |
$27 |
Alliance Global Partners |
January 2, 2025 |
| Alliance Entertainment (NASDAQ: AENT) |
Buy |
$8 |
ThinkEquity |
December 16, 2024 |
| Nova Minerals (NASDAQ: NVA) |
Buy |
$25 |
ThinkEquity |
December 7, 2024 |
| Calidi Biotherapeutics (NYSE American: CLDI) |
Buy |
$10 |
Ladenburg Thalmann |
November 21, 2024 |
| Fathom Holdings (NASDAQ: FTHM) |
Buy |
$3.75 |
Roth |
November 8, 2024 |
| ASP Isotopes (Nasdaq: ASPI) |
Buy |
$4.50 |
Cannacord Genuity |
October 4, 2024 |
| GreenPower Motor (Nasdaq: GP) |
Buy |
$3 |
RF Lafferty |
September 11, 2024 |
| Enlivex Therapeutics (Nasdaq: ENLV) |
Buy |
$13 |
EF Hutton |
August 27, 2024 |
| GreenPower Motor (Nasdaq: GP) |
Buy |
$1.65 |
Roth |
August 15, 2024 |
| Fathom Holdings (NASDAQ: FTHM) |
Buy |
$3 |
DA Davidson |
August 13, 2024 |
|

|
|
|
|
Small Stocks, Big Money™ Podcast
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
|
|
|
|
Upcoming Events
|
|
|
NASDAQ: CNTM - ConnectM Technology Solutions
4:15pm Eastern
ConnectM Technology Solutions is accelerating the transition to an all-electric, net-zero carbon future through its AI-driven energy intelligence platform.
|
|
|
|
NASDAQ: PEV - Phoenix Motorcars
4:15pm Eastern
Phoenix Motor Inc is an electrification solutions provider for the commercial vehicle industry as well as other industries.
|
|
|
|
RedChat
04:15pm Eastern
RedChip Companies has launched RedChat, a cutting-edge AI chatbot designed to revolutionize small-cap stock research.
|
|
|
|
NASDAQ: FTHM - Fathom Holdings
4:15pm Eastern
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent.
|
|
|
|
Archived Events
|
|
|
NYSE American: OSTX - OS Therapies
4:15pm Eastern
OS Therapies, a clinical stage biopharmaceutical company, is at the forefront of developing innovative treatments for Osteosarcoma (OS), breast cancer and other solid tumors.
|
|
|
|
NASDAQ: GP - GreenPower Motor Company
4:15pm Eastern
GreenPower Motor Company is advancing the adoption of electric vehicles (EVs) by making all-electric buses and trucks affordable, durable and easy to deploy.
|
|
|
|
NYSE American: CANF - Can-Fite Biopharma
4:15pm Eastern
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases.
|
|
|
|
NASDAQ: AENT - Alliance Entertainment Holding
11:00am Eastern
Alliance Entertainment is the global leader in physical media distribution, acting as the crucial gateway between major content producers and retailers.
|
|
|
|
Quote of the Week
|
"There are exceptions and dumb luck, but you have to be savvy in this space."
|
|
|
— Greg Sichenzia, Founding Partner Sichenzia Ross Friedman Ference
|
|
|
|
|
RedChip TV
|
|
|
|
RedChip Highlights Calidi Biotherapeutics (NYSE American: CLDI) & OS Therapies (NYSE American: OSTX)
|
|
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Read an interesting perspective on liquidity from leading small-cap manager, Michael Corbett at Perritt Capital.
|
|
|
|
|
|
|